What Dante Moore's NFL decision means for Oregon football's QB room

What does Dante Moore's return to the Ducks in 2026 mean for Dylan Raiola and the UO quarterback room? Here's what to know.
Under30CEO on MSN

Survey signals stronger 2026 deal outlook

Private equity managers and corporate leaders are expressing renewed confidence that could drive a busier mergers and ...
Fierce Pharma

Regulatory tracker: GSK's Exdensur gains approval in 2 indications in Japan

Welcome to Fierce Pharma's regulatory tracker for the first half of 2026. | In this tracker, Fierce Pharma is recording the regulatory progress of in-market products, including expansions into key ...
Yahoo

Outlook Therapeutics receives FDA response on ONS-5010 for wet AMD

LYTENAVA has marketing authorisation in EU and UK for wet AMD from European Commission and MHRA. Credit: New Africa/Shutterstock.com. Outlook Therapeutics has received the US Food and Drug ...
manilatimes

Outlook Therapeutics Provides Regulatory Update on U.S. Food and Drug Administration Review of ONS-5010/LYTENAVA™ (bevacizumab-vikg) for the Treatment of Wet AMD

ISELIN, N.J., Dec. 31, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of ...
Finanznachrichten

Outlook Therapeutics, Inc.: Outlook Therapeutics Provides Regulatory Update on U.S. Food and Drug Administration Review of ONS-5010/LYTENAVA (bevacizumab-vikg) for the ...

ISELIN, N.J., Dec. 31, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of ...
Mena FN

Outlook Therapeutics Provides Regulatory Update On U.S. Food And Drug Administration Review Of ONS-5010/LYTENAVATM (Bevacizumab-Vikg) For The Treatment Of Wet AMD

(MENAFN- GlobeNewsWire - Nasdaq) FDA issues Complete Response Letter (CRL) for resubmitted ONS-5010 BLA ISELIN, N.J., Dec. 31, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a ...